Friday, July 10, 2026

pharma · Pain

Guangzhou General Hospital

Guangzhou General Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Pain. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
3
Patents
0
Clinical program

0.33% ropivacaine 250ml

Approved · small molecule · Pain

0.33% ropivacaine 250ml for Pain is a Approved program (small_molecule) at Guangzhou General Hospital of Guangzhou Military Command with 1 ClinicalTrials.gov record(s).

Internal code local anaesthetic

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Guangzhou General Hospital of Guangzhou Military Command
Phase
Approved
Modality
small_molecule
Indication
Pain
Status
completed
Trials
1